You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
香雪製藥(300147.SZ):2023年度實現營業收入的穩定增長,其中核心業務中成藥版塊營業收入增長超100%
格隆匯 07-16 17:25

格隆匯7月16日丨香雪製藥(300147.SZ)在投資者互動平台表示,隨着國家不斷深化醫療改革,相關政策的持續推進,醫藥行業迎來全領域、全鏈條、全覆蓋的系統治理,面對錯綜複雜的外部環境和內部債務負擔重、運營壓力大等多種超預期的困難挑戰,公司始終把做好產品放在企業經營發展的首位,積極應對挑戰,全力開拓新的市場,推動主營業務的發展,2023年度實現營業收入的穩定增長,其中核心業務中成藥版塊營業收入增長超100%。 公司在通過持續經營產生的現金流維持、改善日常生產經營狀況的同時,將通過向銀行申請借款展期、債務重組、分期償還,出售資產等方式進行償債安排,以優化債務結構。此外,公司也已向地方政府部門、監管機構申請,幫助公司協調債務重組和落實幫扶救助措施,給與公司更多實質性資金融通支持的機會條件,爭取儘快達成債務化解方案,有序化解經營風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account